Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)
每周一次胰高血糖素样肽-1受体激动剂(OW GLP-1RAs)与二肽基肽酶-4抑制剂(DPP-4is)在2型糖尿病血糖控制和体重结果方面的真实世界疗效比较(RELATE)
期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-024-01354-2
Tan, Xi; Divino, Victoria; Amamoo, James; Xie, Lin; Coyle, Katharine B; Gamble, Cory L; Guevarra, Mico; Paprocki, Yurek; King, Aaron A